TRxADE HEALTH Statistics
Total Valuation
TRxADE HEALTH has a market cap or net worth of $20.73 million. The enterprise value is $16.11 million.
| Market Cap | 20.73M |
| Enterprise Value | 16.11M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, after market close.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TRxADE HEALTH has 1.41 million shares outstanding. The number of shares has increased by 88.90% in one year.
| Shares Outstanding | 1.41M |
| Shares Change (YoY) | +88.90% |
| Shares Change (QoQ) | -51.74% |
| Owned by Insiders (%) | 63.99% |
| Owned by Institutions (%) | 10.25% |
| Float | 508,985 |
Valuation Ratios
The trailing PE ratio is 1.31 and the forward PE ratio is 21.83.
| PE Ratio | 1.31 |
| Forward PE | 21.83 |
| PS Ratio | 3.11 |
| Forward PS | 2.80 |
| PB Ratio | 1.52 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 4.00 |
| EV / Sales | 2.42 |
| EV / EBITDA | 2.57 |
| EV / EBIT | 3.06 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.75, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.75 |
| Quick Ratio | 4.70 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | n/a |
| Interest Coverage | 4.26 |
Financial Efficiency
Return on equity (ROE) is 66.00% and return on invested capital (ROIC) is -93.20%.
| Return on Equity (ROE) | 66.00% |
| Return on Assets (ROA) | 29.50% |
| Return on Capital (ROIC) | -93.20% |
| Revenue Per Employee | $832,692 |
| Profits Per Employee | $503,760 |
| Employee Count | 8 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 84.49 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +53.54% in the last 52 weeks. The beta is 2.17, so TRxADE HEALTH's price volatility has been higher than the market average.
| Beta (5Y) | 2.17 |
| 52-Week Price Change | +53.54% |
| 50-Day Moving Average | 10.19 |
| 200-Day Moving Average | 8.41 |
| Relative Strength Index (RSI) | 49.93 |
| Average Volume (20 Days) | 144,154 |
Short Selling Information
The latest short interest is 70,600, so 5.02% of the outstanding shares have been sold short.
| Short Interest | 70,600 |
| Short Previous Month | 6,910 |
| Short % of Shares Out | 5.02% |
| Short % of Float | 13.87% |
| Short Ratio (days to cover) | 0.29 |
Income Statement
In the last 12 months, TRxADE HEALTH had revenue of $6.66 million and earned $4.03 million in profits. Earnings per share was $11.27.
| Revenue | 6.66M |
| Gross Profit | 1.10M |
| Operating Income | -12.88M |
| Pretax Income | 4.03M |
| Net Income | 4.03M |
| EBITDA | 6.27M |
| EBIT | 5.26M |
| Earnings Per Share (EPS) | $11.27 |
Balance Sheet
The company has $4.82 million in cash and $201,584 in debt, giving a net cash position of $4.62 million or $3.28 per share.
| Cash & Cash Equivalents | 4.82M |
| Total Debt | 201,584 |
| Net Cash | 4.62M |
| Net Cash Per Share | $3.28 |
| Equity (Book Value) | 13.62M |
| Book Value Per Share | 9.68 |
| Working Capital | 11.08M |
Cash Flow
In the last 12 months, operating cash flow was -$11.33 million and capital expenditures $87,072, giving a free cash flow of -$11.24 million.
| Operating Cash Flow | -11.33M |
| Capital Expenditures | 87,072 |
| Free Cash Flow | -11.24M |
| FCF Per Share | -$10.85 |
Margins
Gross margin is 16.52%, with operating and profit margins of -193.35% and 60.50%.
| Gross Margin | 16.52% |
| Operating Margin | -193.35% |
| Pretax Margin | 60.50% |
| Profit Margin | 60.50% |
| EBITDA Margin | 94.13% |
| EBIT Margin | 79.03% |
| FCF Margin | -168.80% |
Dividends & Yields
TRxADE HEALTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -88.90% |
| Shareholder Yield | -88.90% |
| Earnings Yield | 19.44% |
| FCF Yield | -54.24% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 22, 2023. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jun 22, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
TRxADE HEALTH has an Altman Z-Score of 4.15 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.15 |
| Piotroski F-Score | 4 |